Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2018
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based TherapyMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
Resuscitation|December 19, 2016
The association of maximum Troponin values post out-of-hospital cardiac arrest with electrocardiographic findings, cardiac reperfusion procedures and survival to discharge: A sub-study of ROC PRIMEDLaurie J Morrison, Sean M Devlin, Michael C Kontos, et al.
The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2018
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based TherapyMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
Resuscitation|December 19, 2016
The association of maximum Troponin values post out-of-hospital cardiac arrest with electrocardiographic findings, cardiac reperfusion procedures and survival to discharge: A sub-study of ROC PRIMEDLaurie J Morrison, Sean M Devlin, Michael C Kontos, et al.
The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
Pageof 18